Welcome to LookChem.com Sign In|Join Free

CAS

  • or

153226-99-4

sodium 5-ethyl-4-{[6-methyl-6-(2H-tetrazol-5-yl)heptyl]oxy}biphenyl-2-olate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

153226-99-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 153226-99-4 Structure

  • Basic information

    1. Product Name: sodium 5-ethyl-4-{[6-methyl-6-(2H-tetrazol-5-yl)heptyl]oxy}biphenyl-2-olate
    2. Synonyms:
    3. CAS NO:153226-99-4
    4. Molecular Formula: C23H29N4O2*Na
    5. Molecular Weight: 416.4917
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 153226-99-4.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 584.9°C at 760 mmHg
    3. Flash Point: 307.5°C
    4. Appearance: N/A
    5. Density: N/A
    6. Vapor Pressure: 2.8E-14mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: sodium 5-ethyl-4-{[6-methyl-6-(2H-tetrazol-5-yl)heptyl]oxy}biphenyl-2-olate(CAS DataBase Reference)
    11. NIST Chemistry Reference: sodium 5-ethyl-4-{[6-methyl-6-(2H-tetrazol-5-yl)heptyl]oxy}biphenyl-2-olate(153226-99-4)
    12. EPA Substance Registry System: sodium 5-ethyl-4-{[6-methyl-6-(2H-tetrazol-5-yl)heptyl]oxy}biphenyl-2-olate(153226-99-4)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 153226-99-4(Hazardous Substances Data)

153226-99-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 153226-99-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,2,2 and 6 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 153226-99:
(8*1)+(7*5)+(6*3)+(5*2)+(4*2)+(3*6)+(2*9)+(1*9)=124
124 % 10 = 4
So 153226-99-4 is a valid CAS Registry Number.

153226-99-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name sodium,4-ethyl-5-[6-methyl-6-(2H-tetrazol-5-yl)heptoxy]-2-phenylphenolate

1.2 Other means of identification

Product number -
Other names 2-Phenyl-4-ethyl-5-[6-(2H-tetrazol-5-yl)-6-methylheptyloxy]phenol sodium salt

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:153226-99-4 SDS

153226-99-4Upstream product

153226-99-4Downstream Products

153226-99-4Relevant articles and documents

Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease

-

, (2008/06/13)

This invention provides methods for the treatment or prevention of Alzheimer's disease which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene antagonist.

SUBSTITUTED PHENYL PHENOL LEUKOTRIENE ANTAGONISTS

-

, (2008/06/13)

Antagonists having a substituted phenyl phenol or a substituted phenolic biphenyl structure, and various derivatives thereof, are specific leukotriene antagonists. Their structures, use and synthesis are disclosed. Also, pharmaceutical formulations are disclosed for use in applications treating diseases or conditions characterized by excessive release of leukotriene B 4, one of the metabolites of arachidonic acid.The primary LTB 4 antagonistic structures are represented as: STR1

USE OF PLA2 INHIBITORS AS TREATMENT FOR ALZHEIMER'S DISEASE

-

, (2008/06/13)

This invention provides methods for the treatment or prevention of Alzheimer's disease in a mammal which comprises administering to a mammal in need thereof an effective amount of an inhibitor of phospholipase A2. This invention also provides a series of compounds which are useful as inhibitors of phospholipases A2, especially cytosolic phospholipase A2.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 153226-99-4